Publicacións (20) Publicacións nas que participase algún/ha investigador/a

2018

  1. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  2. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  3. An rna toolbox for cancer immunotherapy

    Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767

  4. CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes

    Cancer Immunology Research, Vol. 6, Núm. 1, pp. 69-78

  5. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV

  6. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

    Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319

  7. Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

    OncoImmunology, Vol. 7, Núm. 1

  8. Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

    OncoImmunology, Vol. 7, Núm. 2

  9. Epistatic oncogenic interactions determine cancer susceptibility to immunotherapy

    Cancer Discovery, Vol. 8, Núm. 7, pp. 794-796

  10. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

  11. ICAM-1-LFA-1 dependent CD8+ T-lymphocyte aggregation in tumor tissue prevents recirculation to draining lymph nodes

    Frontiers in Immunology, Vol. 9, Núm. SEP

  12. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect

    Trends in Immunology, Vol. 39, Núm. 8, pp. 644-655

  13. Immunotherapy of hepatocellular carcinoma: Facts and hopes

    Clinical Cancer Research, Vol. 24, Núm. 7, pp. 1518-1524

  14. Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies

    Blood, Vol. 131, Núm. 1, pp. 49-57

  15. Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation

    Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811

  16. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

    Blood cancer journal, Vol. 8, Núm. 12, pp. 117

  17. Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  18. Radiation effects on antitumor immune responses: Current perspectives and challenges

    Therapeutic Advances in Medical Oncology, Vol. 10

  19. Revisiting interleukin-12 as a cancer immunotherapy agent

    Clinical Cancer Research, Vol. 24, Núm. 12, pp. 2716-2718

  20. Starting the fight in the tumor: Expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

    Annals of Oncology, Vol. 29, Núm. 11, pp. 2163-2174